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Abstract: Chronic colonization and infection of the lung with Pseudomonas aeruginosa is a major cause of morbidity and 
mortality in cystic fibrosis (CF) patients. Imundo, et al. determined that CF cells had a higher concentration of an 
asialoganglioside (asialo-GM1), to which both P. aeruginosa and S. aureus bound preferentially. We sought to determine 
if the expression of mutant CFTR is associated with altered sialylation. Our study of epithelial cells transfected with 
normal and mutant F508 CFTR, the defect in the majority of CF patients in the United States, were analyzed by ELISA 
and FACS analysis of cell membranes labeled with lectins which bind to Neu5Ac. We determined that F508 CFTR is 
associated with decreased membrane sialic acid residues in the 2, 3 position and increased concentrations of asialo-
GM1. Quantitation of sialic acids released from the cellular membranes demonstrated that the presence of the F508 
CFTR is associated with markedly decreased membrane sialylation, but similar cytoplasmic sialylation. Thus, F508 
defect is correlated with decreased expression of GM1 and with decreased sialylation of all cell surface structures, and this 
change occurs during post-translational modification of glycoproteins and glycolipids. This may be one factor involved in 
the chronic bacterial colonization seen in these patients. 
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INTRODUCTION 
  Cystic fibrosis (CF) is characterized by abnormal 
epithelial ion and fluid transport and is associated with 
mutations in the CF gene product, the cystic fibrosis 
transmembrane conductance regulator (CFTR) protein. 
Although much about function and regulation of normal 
CFTR is known [1-3], the precise cellular pathways that are 
affected in CF are still under investigation. The most 
common mutation of CFTR, affecting approximately 90% of 
patients, is a deletion of phenylalanine at codon 508 (F508 
CFTR) [2]. The major cause of morbidity in the clinical 
disease is chronic pulmonary colonization and infection with 
P. aeruginosa [4-6] and S. aureus. Imundo, et al. [1] has 
demonstrated that CF epithelial cells have increased binding 
of  P. aeruginosa and  S. aureus. Since these bacteria 
recognize and bind to the GaINAc1-4Gal disaccharide 
sequence in asialo-GM1 and asialo-GM2 [7, 8] preferentially 
to GM1 and GM2, bacterial colonization may be related to 
altered sialylation of CF cells. Further work is needed in the 
study the relationship between sialylation and bacterial 
colonization in human CF cells. Abnormalities in sialylation 
of cells transfected with mutant CFTR and secretions of 
patients with CF have been described [9]; however, it has not 
been clear whether this phenomenon has been directly 
mediated by the presence of neuraminidases in colonizing 
bacteria or by the abnormal CFTR. 
 Mammalian  cells  expressing  F508 CFTR have been 
shown to have ion permeability changes, presumably due to  
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the fact that the mutant protein fails to exit from the 
endoplasmic reticulum (ER) and localize normally in the 
plasma membrane [10]. The F508 CFTR has normal 
chloride channel function in the ER [11], and when it 
reaches the apical membrane in a low temperature 
environment, as can be performed using cell culture of some 
cell types. However, under growth conditions at physiologic 
temperatures, the F508 CFTR has less stability than the 
normal CFTR [11]. Although cells from CF patients may 
have abnormal transport pathways, including those driven by 
agonists (cAMP) [2] and inhibitors ((D)-Ins [3-6] P4) [12, 
13], it is not obvious how these differences affect post-
translational modification of glycoproteins and glycolipids. 
Thus the relationship between the Golgi, the cellular 
compartment in which post-translational modifications such 
as addition of sialic acids by sialyltransferases occurs [9, 14], 
and the CFTR may be important in disease pathogenesis. 
  This study was conducted to qualitatively and 
quantitatively  compare the expression of sialylated 
glycoconjugates and gangliosides on the cell membranes of 
CI27 mouse mammary epithelial cells transfected with 
normal CFTR protein, F508 CFTR, or vector alone, to 
determine whether altered sialylation is associated with 
heterologous expression of the CFTR F508 mutation. We 
used a combination of ELISA, immunocytochemistry and 
FACS to demonstrate the differential presence of sialic acid 
residues recognized by specific lectins and quantitative sialic 
acid analysis, and to determine whether the F508 mutation 
of the CFTR is responsible for the sialylation defects noted 
in this common form of cystic fibrosis. 
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MATERIALS AND METHODS 
Reagents 
  Fluorescein and Biotin conjugates of Maackia amaurensis 
lectin (MAL II), avidin D-alkaline phosphatase, Vector 
Laboratories (Burlingame, CA); biotinlylated conjugate of 
cholera toxin, List Biological Lab, Campbell, CA.; N-
acetylneuraminic acid and N-glycolylneuraminic acid1,2 
diamino-4,5-methylenedioxybenzene, N-propyl gallate, N-
ethylmaleimide, PMSF, leupeptin, TBST, goat anti-rabbit 
alkaline phosphatase, Sigma Chemical Company, St. Louis, 
MO; Biorad protein standard assay, alkaline phosphatase 
substrate kit (p-nitrophenylphosphate, diethanolamine buffer), 
BioRad, Hercules, CA. All other chemicals were of reagent 
grade and were purchased from commercial sources. 
Transfected Cell Lines 
  Mouse mammary C127 epithelial cells, which do not 
express detectable levels of CFTR [15], transfected with 
bovine papilloma-based vector containing CFTR cDNA 
(WT), a CFTR cDNA with the F508 mutation (F508) 
(generously provided  by the Genzyme Corporation, 
Framingham, MA), or vector alone (BPV) were used, as 
described [15]. These cell lines have been used in previous 
experiments on CFTR and processing defects and efficiency 
of transfection was confirmed [15]. Cell lines were 
maintained in Dulbecco's modified Eagle's medium 
(DMEM) with 10% fetal calf serum in an atmosphere of 5% 
CO2 and were passaged each week. Confluent monolayers 
were used for experiments at days 2-5 after passaging. 
Immunocytochemistry 
  Cells were grown to a monolayer on glass coverslips and 
fixed with 4%  paraformaldehyde in PBS (0.9% NaCI in 
10mM sodium phosphate  buffer, pH 7.4) containing 5% 
sucrose for two hours at room temperature; coverslips were 
then washed with PBS. The cells were incubated with MAL 
II (20μg/ml) for 60 minutes followed by avidin D-FITC (10 
μg/ml) for 30 minutes, pH 7.4 at room temperature. The 
coverslips were washed between incubations with PBS and 
mounted in PBS-glycerol, pH 8.0, with 2% N-propyl gallate 
as an anti-quenching agent. The slides were viewed on a 
Nikkon epifluorescence microscope and photographs were 
taken on Kodak 3200 film [15]. 
Membrane Preparation 
  For ELISA assay, adherent cells were rinsed in cold PBS 
and then 3-5 ml of homogenization buffer (0.25 M sucrose, 
10mM Tris, 1mM EDTA pH 7.4) was added to each dish. 
The cells were scraped and dounced. The nuclear pellet was 
discarded after the cells were centrifuged at 500 x g for 10 
minutes at 4°C. The supernatant was then centrifuged at 
100,000 x g for 2 hours at 4° C. This supernatant (cytosol) 
and pellet (membrane) were saved at -70° C and a small 
aliquot from each was used for protein determination by 
Biorad protein standard assay using BSA as the standard. 
Membrane protein isolates were treated with lysate buffer 
(20mM Tris-HCI pH 8.0, 100mM NaCI, 1% Triton X 100, 
10mM NEM, 2mM PMSF, 0.1% leupeptin). 
  For sialic acid analysis adherent cells were rinsed in cold 
PBS, the plates were scraped and washed three times in ice 
cold PBS containing 2mM PMSF, 0.1% leupeptin. Pellets 
resuspended in 500 uL PBS were homogenized using ten 5-
second pulses with a Polytron homogenizer (Brinkmann). 
The nuclear pellet was discarded after the cells were 
centrifuged at 500 x g for 10 minutes. The supernatant was 
ultracentifuged at 100,000 x g for 1 hour. The supernatant 
was reserved and the membrane pellet resuspended in 50 
mM Tris, pH 7.4 and a small aliquot saved for protein 
determination using the method of Lowry [16]. 
ELISA Assay 
  High affinity flat bottomed 96 well ELISA plates 
(Immulon 3, Dynatech Laboratories Inc, Chantilly, Virginia) 
were coated and incubated with serially diluted membrane 
proteins, overnight at 4°C. The plates were washed with 
TBST pH 7.6, Tris buffered saline (IM Tris-HCI, 1M Tris 
Base, 1.5 M NaCI) with 5% Tween between incubation 
times. The plates were then blocked with 1% gelatin for one 
hour. The plates were again washed with TBST. The primary 
antibody or lectin-biotin was applied to each well. The 
lectins were diluted in PBS. Cholera Toxin (0.1 mg/ml) 
conjugated to biotin was used in the same manner as lectins. 
For assaying binding of lectins and cholera toxin, the wells 
were then washed and incubated for one hour with avidin D-
alkaline phosphatase. The plates were then washed several 
times and reacted with alkaline phosphatase substrate kit (p-
nitrophenyl phosphate, diethanolamine buffer). The reaction 
was stopped with 2M NaOH and read at 410 nm on an 
ELISA reader (Dynatech Laboratories Inc. MR700). The p 
values were calculated by the student t test, or ANOVA as 
appropriate, using triplicate data points from each of the 
analyses. 
Release and Analysis of Sialic Acids 
  Sialic acids were released by adding acetic acid to a final 
of 2M acetic acid, and heating at 80oC for 3 hours [17, 18]. 
Membranes were pelleted by centrifugation at 12,000 g for 5 
minutes; supernatants were centrifuged through a 
Microcon
TM  10,000 m.w. cut off filter for 30 minutes. 
Supernatants were treated with 0.1 M NaOH for 30 minutes 
at 22°C followed by addition of an equal volume of 0.1M 
HCl; they were then kept at -70oC until analysis. 
  Aliquots containing released sialic acids were derivatized 
for 2.5 hours at 50oC with DMB, as described [19, 20]. 
HPLC was carried out using a TSK gel ODS-120T column 
eluted in the isocratic mode with a mixture of acetonitrile-
methanol-water (9:7:84, v/v) at a flow rate of 1.0 ml/min at 
22oC. Effluent was monitored using a Linear Fluor LC 304 
fluorescence detector at an excitation wavelength 374 
emission wavelength 448. Integration areas were compared 
to sialic acid standards and expressed as picomoles sialic 
acid per milligram of protein in the sample. Duplicate 
injections were analyzed from each of four separate 
membrane preparations. 
Flow Cytometry 
  A fluorescence activated cell sorter (FACScan, Becton 
Dickinson and Co, Mountain View, CA) was used to 
determine the presentation of sialo GM1 on the epithelial cell 
surfaces of WT, F508, and BPV cells using the -subunit of 
cholera toxin, which binds to GM1. Confluent layers of cells 
were dissociated with 0.25% trypsin at 37oC for 10 minutes, 
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counted and divided into 1 x10
5 cell aliquots. The cells were 
washed in PBS and incubated for 60 minutes at room 
temperature with cholera toxin -subunit, diluted 1:50 (0.1 
mg/ml) in PBS-BSA. After the primary incubation, cells were 
washed three times with PBS and reacted with 1:100 Goat 
anti-rabbit FITC for 60 minutes with end-over-end rotation. 
After washing in PBS, cells were fixed in 1% 
paraformaldehyde. Approximately 10,000 events were 
recorded. An aliquot was used as a control for nonspecific 
binding using cells from each cell line labeled with FITC 
conjugate alone. 
RESULTS 
F508 Cells have Fewer Receptors for Maackia 
Amaurensis Lectin (MAL II) 
  MAL II binds to sialic acids in the Neu5Ac 2,3 
Gal/GalNAc sequence [21]. As can be seen in Fig. (1), the 
MAL II binds intensely to the surfaces of WT and BPV cells. 
Membrane staining is marked by linear fluorescence along 
the borders of confluent monolayers and diffuse punctate 
staining over the rest of the cell surfaces. In contrast F508 
cells have less staining at both complete confluence and at 
low density, indicating that plating density is not relevant. 
This finding suggests that 2, 3 sialic acid moieties that bind 
to the lectin are present on WT cells but are diminished on 
the cell surfaces of F508 cells. While this is a qualitative 
analysis, the differences between staining and absence of 
staining are evident. The lighter staining observed with the 
BPV cells, may be artifactual or a reflection of intermediate 
presentation of sialic acid moieties in cells without CFTR. 
ELISA Assays on Membrane Isolates Demonstrate 
Differences in Surface Sialic Acids in WT and BPV Cells 
Compared to F508 Cells 
MAL II 
  As shown in Fig. (2) in which ELISA assays using MAL 
II are shown, the F508 line have lower absorbance readings 
at all concentrations ranging from 12.5 μg to 100 μg 
compared to the WT and BPV cell lines (p<0.0005). The 
membrane sialic acid 2,3 residues recognized by MAL II of 
the F508 line are consistently reduced when compared to 
the WT and BPV cells. 
Cholera Toxin 
  Cholera toxin binds specifically to the carboxyl group of 
the Neu5Ac moiety and the terminal galactose of GM1 [22]. 
The binding of cholera toxin -biotin to the cell membrane 
isolates was measured by spectrophotometric reaction of 
Avidin D and substrate with bound cholera toxin  subunit-
biotin. The F508 line has significantly less (p<0.05) 
binding of the cholera toxin  subunit compared to WT and 
BPV cell lines in nine experiments. The F508 cells have 
fewer GM1 gangliosides as measured by this assay (Fig. 3). 
As shown, the absorbance reading that corresponds to the 
binding of cholera toxin is less in F508 cells compared to 
either WT or BPV cells. 
Flow Cytometry 
  A FACScan analysis of sialo-GM1 receptors for cholera 
toxin  -subunit demonstrates that F508 cells have a   
 
 
Fig. (1). Results of Immunocytochemistry. Differential binding of 
MAL II Lectin-FITC to transfected cell lines. In panels A (BPV) 
and C (WT) there is notable binding of MAL II Lectin-FITC, which 
binds selectively to sialic acid at the 2, 3 position on cell borders. 
Panel B (F508) has a qualitative decrease in binding to this lectin. 
Bar =10um. 
significantly decreased presentation of such GM1 sites 
compared to WT cells, as shown in Fig. (4). When cells of 
each cell line are analyzed by fluorescent emission at 540 
nm, there is a consistent shift in fluorescence absorption 
between F508 and WT cells in two analyses. These results 
are consistent with those obtained on ELISA. 
  F508 CFTR cells have decreased surface membrane 
sialic acids compared to controls. 
  Total amounts of sialic acids released and purified as 
described in “Materials and Methods" were determined by 
comparison of calculated area under the curve of duplicate 
samples compared to sialic acid standards. As has been 
previously demonstrated [19, 20] this technique is sensitive 
to low picomolar amounts of total sialic acids per mg protein  
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Fig. (2). ELISA of cellular membrane isolates using MAL II. 
Results of incubation with MAL II with several concentrations of 
membrane proteins by ELISA (see Materials and Methods). 
Membrane protein concentration is on x-axis and absorbance 
reading on y-axis. Closed circles, WT; closed squares, BPV; open 
squares,  F508. The F508 membranes have significantly less 
MAL II binding (p<0.0005) compared to either BPV or WT lines. 
 
Fig. (3). ELISA of cellular membrane isolates using cholera toxin  
subunit. Cellular membranes from BPV, WT and F508 cell lines 
were incubated with cholera toxin  subunit, which binds 
preferentially to GM1. Protein concentration is plotted on the x-axis 
and absorbance on the y-axis. Closed circles, WT; closed squares 
depict BPV; F508 open squares. The F508 membranes have 
decreased binding (p<0.05) compared to WT and BPV cells. 
and is reproducible. For this analysis all sialic acids were 
converted to the parent conformation by treatment with 0.1M 
NaOH prior to analysis; this step was performed to increase 
reproducibility of results even though the only sialic acid 
noted in untreated samples was Neu5Ac. As can be seen in 
Fig. (5), the F508 membranes have markedly less total 
membrane sialic acid compared to either WT or BPV cell 
membranes. This is consistent with the results of FACScan, 
ELISA and immunocytochemistry results which demonstrate 
that sialic acids in 2,3 linkages are decreased in F508 
cells. 
  F508 CFTR cells have similar cytoplasmic levels of 
sialic acids compared to controls. 
  Total amounts of sialic acids from the cytoplasmic 
compartment from two separate preparations released and 
purified as described in “Materials and Methods" were 
determined by comparison of calculated area under the curve 
of duplicate samples compared to sialic acid standards. This 
analysis demonstrates that the levels of sialic acids in the 
cytoplasm of all cell types are equivalent: WT: 675 
pmol/mg, BPV: 623 pmol/mg, F508: 821 pmol/mg (mean 
values of duplicates from two separate preparations). This 
implies that the CFTR is not required for sialic acid synthesis 
and that the F508 mutation does not alter synthesis of sialic 
acids. 
 
Fig. (4). Flow cytometry of cell lines using cholera toxin-biotin 
probe. FACScan using a cholera toxin-biotin probe reacted with 
avidin D-Alkaline Phosphatase shows that the F508 cells (closed 
squares) have less fluorescence than the WT (closed circles) cell 
lines. This result is consistent with the ELISA shown in Fig. (3). 
 
Fig. (5). Quantitation of membrane-bound sialic acids. Cells from 
BPV, WT, and F508 lines were fractionated by ultracentrifugation 
(see Materials and Methods), sialic acids were released and 
quantified using derivatization with DMB over a TSK-ODS-120T 
column. The sialic acids are expressed as picomoles Neu5Ac 
released relative to protein in the membrane preparation, as 
determined by the Lowry method. Error calculated using a student t 
test. The cell lines are designated as: WT, solid; BPV, shaded; 
F508, clear. 
DISCUSSION 
  This study shows that the heterologous expression of 
F508 CFTR in cells which do not normally express CFTR 
results in a quantitative decrease in the sialylation of cell 
membrane glycoconjugates. The specific binding of lectins 
to sialic acids in the Neu5Ac2,3 GaI1-4GlcNAc linkage is 
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with the F508 CFTR. The cells with F508 CFTR also 
have a lower level of GM1, as evidenced by decreased 
binding to cholera toxin. 
  Previous studies have shown an alteration of 
glycosylation in cystic fibrosis cells and secreted mucous 
glycoproteins [23]. This study provides direct evidence for a 
sialylation defect of cells expressing F508 CFTR and 
corroborates reports using qualitative observations using 
lectin and antibody binding to detect membrane sialic acids 
[15]. 
  The precise role of CFTR in the trafficking of proteins 
and gangliosides to the cell surface has not been elucidated. 
The results from this study indicate that the CFTR is not 
required for normal sialylation because the BPV cells and 
WT cells have equivalent sialylation of cytosolic 
components. It is possible that the over-expression of the 
F508 CFTR, retained in the RER at physiologic 
temperatures, leads to altered sialylation by a previously 
undescribed pathway. However, it seems more likely that the 
differences in sialylation are either due to differences in 
activity of sialyltransferases or to differences in processing 
and re-utilization of cell membrane components. One 
hypothesis is that the F508 CFTR defect induces defective 
acidification of Golgi vesicles, which could decrease activity 
of pH-dependent sialyltransferases, but Verkman, using 
ratio-imaging confocal microscopy with liposomal injection 
into the lumen of trans-Golgi has provided direct evidence 
that pH of the trans-Golgi compartment is not altered by 
CFTR expression and activation [24]. One recent study even 
indicates that hyperacidification of the trans-Golgi network 
in CF lung epithelial cells leads to undersialylation of plasma 
membrane glycoconjugates, which in turn promote lung 
pathology and bacterial colonization [25]. 
  Verkman’s additional studies indicated that the CFTR is 
involved in endosomal fusion, which could alter processing 
and distribution of membrane components [3], thus 
providing an alternative hypothesis for defective post-
translational modifications. Duncan and Kornfeld reported 
that internalized proteins are exposed to a sialyltransferase in 
the trans-Golgi network in approximately 10% of 
internalization cycles [14]. Therefore, defective vesicle 
fusion, defective sialyltransferase activity, or a combination 
of the two may lead to altered post-translational modification 
of proteins and lipids, as occurs in the cells expressing 
F508 CFTR. Metabolic labeling of these cells with sialic 
acid precursors would determine the temporal sequence for 
the differences in sialylation, and may help explain the 
mechanism by which the differences occur. 
  An increase of asialo-GM1  in cells with the F508 
CFTR mutation is important because presentation of the 
Gal1-3GalNAc1-4 Gal1-4 Glc-ceramide of asialo-GM1 
serves as a receptor for Pseudomonas and other bacteria, 
such as S. aureus and K. pneumoniae [1]. A decrease in 
membrane sialylation of GM1 is likely to be responsible for 
characteristic pulmonary infections that contribute to the 
morbidity and mortality of CF [26]. It is also likely that 
altered membrane sialylation plays a role in decreased 
incidence of gastrointestinal infections with Salmonella typhi 
[27]. Less clear is whether altered membrane sialylation 
plays a role in the pathophysiology of chronic pancreatitis, 
the incidence of which is increased in patients with 
abnormalities of CFTR [28], but which is apparently 
unrelated to bacterial infection. Further work will be 
necessary to clarify whether altered sialylation in cells that 
express F508 CFTR may contribute to other facets of the 
clinical presentation. Based on these and other studies the 
undersialylation of plasma membrane glycoconjugates in 
patients with CF may promote lung pathology associated 
with chronic bacterial colonization of the lung. 
ABBREVIATIONS 
BSA  =  Bovine serum albumin 
DMB =  1,2  Diamino-4,5-methylenedioxybenzene 
ELISA  =  Enzyme linked immunoabsorbant assay 
GM1 =  Gal1-3GalNAc1-4 Gal1-4 Glc 
NEM =  N-ethylmaleimide 
PBS  =  phosphate buffered saline 
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